Cefmenoxime

Cefmenoxime

Clinical data
Routes of administration	Intramuscular, intravenous
ATC code	J01DD05 (WHO)
Pharmacokinetic data
Bioavailability	100% (given IM)
Protein binding	50% to 70%
Metabolism	Negligible
Elimination half-life	1 hour
Excretion	Renal, unchanged
Identifiers
IUPAC name (6R,7R)-7-{[(2E)-2-(2-amino-1,3-thiazol-4-yl)- 2-methoxyimino-acetyl]amino}-3-[(1-methyltetrazol- 5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylic acid
CAS Number	65085-01-0
PubChem CID	5361486
DrugBank	APRD00851
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C16H17N9O5S3
Molar mass	511.562 g/mol

WikiDoc Resources for Cefmenoxime
Articles
Most recent articles on Cefmenoxime Most cited articles on Cefmenoxime Review articles on Cefmenoxime Articles on Cefmenoxime in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Cefmenoxime Images of Cefmenoxime Photos of Cefmenoxime Podcasts & MP3s on Cefmenoxime Videos on Cefmenoxime
Evidence Based Medicine
Cochrane Collaboration on Cefmenoxime Bandolier on Cefmenoxime TRIP on Cefmenoxime
Clinical Trials
Ongoing Trials on Cefmenoxime at Clinical Trials.gov Trial results on Cefmenoxime Clinical Trials on Cefmenoxime at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Cefmenoxime NICE Guidance on Cefmenoxime NHS PRODIGY Guidance FDA on Cefmenoxime CDC on Cefmenoxime
Books
Books on Cefmenoxime
News
Cefmenoxime in the news Be alerted to news on Cefmenoxime News trends on Cefmenoxime
Commentary
Blogs on Cefmenoxime
Definitions
Definitions of Cefmenoxime
Patient Resources / Community
Patient resources on Cefmenoxime Discussion groups on Cefmenoxime Patient Handouts on Cefmenoxime Directions to Hospitals Treating Cefmenoxime Risk calculators and risk factors for Cefmenoxime
Healthcare Provider Resources
Symptoms of Cefmenoxime Causes & Risk Factors for Cefmenoxime Diagnostic studies for Cefmenoxime Treatment of Cefmenoxime
Continuing Medical Education (CME)
CME Programs on Cefmenoxime
International
Cefmenoxime en Espanol Cefmenoxime en Francais
Business
Cefmenoxime in the Marketplace Patents on Cefmenoxime
Experimental / Informatics
List of terms related to Cefmenoxime

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Cefmenoxime is a third-generation cephalosporin antibiotic.

External links

• Template:DiseasesDB
• Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Deguchi K, Oda S, Tanaka S, Nakane Y, Fukumoto T (1995). "Antibacterial activities of cefmenoxime against recent fresh clinical isolates from patients in sinusitis". Jpn J Antibiot. 48 (5): 602–9. PMID 7637194.CS1 maint: Multiple names: authors list (link)
• Paladino J, Fell R (1994). "Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia". Ann Pharmacother. 28 (3): 384–9. PMID 8193431.
• Duncker G, Reich U, Krausse R (1994). "Cefmenoxime in corneal organ culture". Ophthalmologica. 208 (5): 262–6. PMID 7816419.CS1 maint: Multiple names: authors list (link)